With new immune checkpoint inhibitors being utilized in treating patients with ICC, physicians need to study new ways to address irAEs associated with this treatment.
Sarah Abou Alaiwi, MD
Advertisement
Articles by Sarah Abou Alaiwi, MD
Advertisement
Latest Updated Articles
Expert Discusses Studying irAEs in Patients With ICCPublished: November 26th 2019 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Sub-Q Mosunetuzumab Wins FDA Approval in R/R Follicular Lymphoma
2
Opinion: CAR T-Cell Therapy Shows Promise in Gastric and GEJ Cancers
3
Real, Placebo Acupuncture Improve Cognitive Outcomes in Breast Cancer Survivors
4
FDA OKs Subcutaneous Amivantamab Across All NSCLC Indications
5